Gilbert DL - Search Results

1

Motor cortex inhibition: a marker of ADHD behavior and motor development in children.

Gilbert DL, Isaacs KM, Augusta M, Macneil LK, Mostofsky SH. Gilbert DL, et al. Neurology. 2011 Feb 15;76(7):615-21. doi: 10.1212/WNL.0b013e31820c2ebd. Neurology. 2011. PMID: 21321335 Free PMC article.

2

Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial.

Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR. Gilbert DL, et al. Neurology. 2000 Mar 28;54(6):1310-5. doi: 10.1212/wnl.54.6.1310. Neurology. 2000. PMID: 10746603 Clinical Trial.

3

Tic reduction with pergolide in a randomized controlled trial in children.

Gilbert DL, Dure L, Sethuraman G, Raab D, Lane J, Sallee FR. Gilbert DL, et al. Neurology. 2003 Feb 25;60(4):606-11. doi: 10.1212/01.wnl.0000044058.64647.7e. Neurology. 2003. PMID: 12601100 Clinical Trial.

4

Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome.

Gilbert DL, Bansal AS, Sethuraman G, Sallee FR, Zhang J, Lipps T, Wassermann EM. Gilbert DL, et al. Mov Disord. 2004 Apr;19(4):416-25. doi: 10.1002/mds.20044. Mov Disord. 2004. PMID: 15077239

5

Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome.

Gilbert DL, Sallee FR, Zhang J, Lipps TD, Wassermann EM. Gilbert DL, et al. Biol Psychiatry. 2005 Jun 15;57(12):1597-600. doi: 10.1016/j.biopsych.2005.02.022. Biol Psychiatry. 2005. PMID: 15953499 Clinical Trial.

6

Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex.

Gilbert DL, Ridel KR, Sallee FR, Zhang J, Lipps TD, Wassermann EM. Gilbert DL, et al. Neuropsychopharmacology. 2006 Feb;31(2):442-9. doi: 10.1038/sj.npp.1300806. Neuropsychopharmacology. 2006. PMID: 16034446 Clinical Trial.

7

An updated review of the long-term neurological effects of galactosemia.

Ridel KR, Leslie ND, Gilbert DL. Ridel KR, et al. Among authors: gilbert dl. Pediatr Neurol. 2005 Sep;33(3):153-61. doi: 10.1016/j.pediatrneurol.2005.02.015. Pediatr Neurol. 2005. PMID: 16087312 Review.

8

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.

Allen AJ, Kurlan RM, Gilbert DL, Coffey BJ, Linder SL, Lewis DW, Winner PK, Dunn DW, Dure LS, Sallee FR, Milton DR, Mintz MI, Ricardi RK, Erenberg G, Layton LL, Feldman PD, Kelsey DK, Spencer TJ. Allen AJ, et al. Among authors: gilbert dl. Neurology. 2005 Dec 27;65(12):1941-9. doi: 10.1212/01.wnl.0000188869.58300.a7. Neurology. 2005. PMID: 16380617 Clinical Trial.

9

Motor cortex inhibitory function in Tourette syndrome, attention deficit disorder, and obsessive compulsive disorder: studies using transcranial magnetic stimulation.

Gilbert DL. Gilbert DL. Adv Neurol. 2006;99:107-14. Adv Neurol. 2006. PMID: 16536356 Review. No abstract available.

10

Dopamine transporter genotype influences the physiological response to medication in ADHD.

Gilbert DL, Wang Z, Sallee FR, Ridel KR, Merhar S, Zhang J, Lipps TD, White C, Badreldin N, Wassermann EM. Gilbert DL, et al. Brain. 2006 Aug;129(Pt 8):2038-46. doi: 10.1093/brain/awl147. Epub 2006 Jun 7. Brain. 2006. PMID: 16760197 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page